Clinical Trial/Study

Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new Medtronic CoreValve Evolut R System.

TCT 2014, late breaking trials, late breaking presentations

Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept. 13-17.

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according to preliminary hot line results presented at the 201...

August 21, 2014 — Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop in the rate of hospitalizations and deaths, accordin...

BioControl Medical Enrollment INOVATE-HF Study CardioFit System Heart Failure
BioControl Medical announced that it has reached an important clinical trial milestone, reaching 480 randomized subjects — or 70 percent — of the...
September 16, 2014 — A quarter of adults in the United States have two or more chronic medical conditions, as do more than two-thirds of seniors, yet there are...
Tryton Medical First U.S. Patient Extended Access Registry
Tryton Medical Inc. announced that the first patient in the United States has been enrolled in the Extended Access Registry, a single arm study of its Tryton...
PressureWire St. Jude Medical Two-year FAME 2 Data FFR-guided PCI
St. Jude Medical Inc. announced primary outcome two-year data from the FAME 2 Trial, which demonstrated sustained superiority with FFR-guided PCI using St....
Covidien DEFINITIVE LE Study Peripheral Artery Disease
The Solitaire Flow Restoration Device from Covidien is among a new generation of devices designed to remove blood clots from blocked brain...
Tilda, Vigila and Celerity leads offer a complete package for physicians to better manage their patients’ individualized needs. Tilda...
The U.S. Food and Drug Administration (FDA) in April 2012 approved an expanded indication for Medtronic’s cardiac resynchronization therapy...

Articles

Medtronic U.S. Implants Clinical Study Recapturable CoreValve Evolut R
Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new...
September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease...
Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy
Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien...
Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien...

Video Center

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
2 weeks 9 hours ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
7 weeks 5 days ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
10 weeks 10 hours ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...

Comparison Charts

Sorry there is no data available